PROFOUND MEDICAL CORP. Weighted Average Share Price Share Options Granted2019
PROFOUND MEDICAL CORP. (PROF) had Weighted Average Share Price Share Options Granted2019 of 12.41 CAD/shares as of 2023-11-16, per its 40-F filed 2024-03-07.
Discontinued › Notes › Per Share
ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019 · last filed 2024-03-07
- 2023-11-16: Weighted Average Share Price Share Options Granted2019 12.41 CAD/shares.
- 2023-09-08: Weighted Average Share Price Share Options Granted2019 12.38 CAD/shares.
- 2023-06-12: Weighted Average Share Price Share Options Granted2019 19.87 CAD/shares.
- 2023-03-22: Weighted Average Share Price Share Options Granted2019 13.39 CAD/shares.
CAD/shares
| Period end | Weighted Average Share Price Share Options Granted2019 |
|---|---|
| 2023-11-16 | 12.41 CAD/shares 40-F · filed 2024-03-07 |
| 2023-09-08 | 12.38 CAD/shares 40-F · filed 2024-03-07 |
| 2023-06-12 | 19.87 CAD/shares 40-F · filed 2024-03-07 |
| 2023-03-22 | 13.39 CAD/shares 40-F · filed 2024-03-07 |
| 2022-12-20 | 12.46 CAD/shares 40-F · filed 2024-03-07 |
| 2022-08-15 | 9.20 CAD/shares 40-F · filed 2024-03-07 |
| 2021-12-30 | 14.90 CAD/shares 40-F · filed 2023-03-07 |
| 2021-11-15 | 14.96 CAD/shares 40-F · filed 2023-03-07 |
| 2021-06-17 | 23.14 CAD/shares 40-F · filed 2023-03-07 |
| 2021-05-21 | 22.08 CAD/shares 40-F · filed 2023-03-07 |
| 2021-03-11 | 28.16 CAD/shares 40-F · filed 2023-03-07 |
| 2020-12-22 | 25.01 CAD/shares 40-F · filed 2022-03-03 |
| 2020-12-15 | 23.02 CAD/shares 40-F · filed 2022-03-03 |
| 2020-11-16 | 24.31 CAD/shares 40-F · filed 2022-03-03 |
| 2020-08-17 | 20.39 CAD/shares 40-F · filed 2022-03-03 |
| 2020-06-08 | 16.87 CAD/shares 40-F · filed 2022-03-03 |
| 2020-05-20 | 17.44 CAD/shares 40-F · filed 2022-03-03 |
| 2020-03-12 | 15.15 CAD/shares 40-F · filed 2022-03-03 |
| 2019-11-18 | 11.08 CAD/shares 40-F · filed 2020-03-03 |
| 2019-05-16 | 9.40 CAD/shares 40-F · filed 2020-03-03 |
| 2019-05-15 | 9.10 CAD/shares 40-F · filed 2020-03-03 |
USD/shares
| Period end | Weighted Average Share Price Share Options Granted2019 |
|---|---|
| 2020-12-22 | $22.90 40-F · filed 2021-03-02 |
| 2020-12-15 | $18.24 40-F · filed 2021-03-02 |
| 2020-11-16 | $19.23 40-F · filed 2021-03-02 |
| 2020-08-17 | $15.02 40-F · filed 2021-03-02 |
| 2020-06-08 | $12.61 40-F · filed 2021-03-02 |
| 2020-05-20 | $12.55 40-F · filed 2021-03-02 |
| 2020-03-12 | $10.96 40-F · filed 2021-03-02 |
| 2019-11-18 | $8.50 40-F · filed 2021-03-02 |
| 2019-05-16 | $6.85 40-F · filed 2021-03-02 |
| 2019-05-15 | $6.72 40-F · filed 2021-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |